SE9303740L - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- SE9303740L SE9303740L SE9303740A SE9303740A SE9303740L SE 9303740 L SE9303740 L SE 9303740L SE 9303740 A SE9303740 A SE 9303740A SE 9303740 A SE9303740 A SE 9303740A SE 9303740 L SE9303740 L SE 9303740L
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical composition
- abnormalities
- mammal
- calcium
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
Abstract
The invention concerns the use of clodronic acid or a salt thereof for making a pharmaceutical composition for the rectal treatment of abnormalities in the calcium and phosphate metabolism in a mammal.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303740A SE9303740L (en) | 1993-11-12 | 1993-11-12 | Pharmaceutical composition |
PCT/FI1994/000504 WO1995013078A1 (en) | 1993-11-12 | 1994-11-09 | Pharmaceutical composition and use thereof |
AU81083/94A AU8108394A (en) | 1993-11-12 | 1994-11-09 | Pharmaceutical composition and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9303740A SE9303740L (en) | 1993-11-12 | 1993-11-12 | Pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9303740D0 SE9303740D0 (en) | 1993-11-12 |
SE9303740L true SE9303740L (en) | 1995-05-13 |
Family
ID=20391728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9303740A SE9303740L (en) | 1993-11-12 | 1993-11-12 | Pharmaceutical composition |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU8108394A (en) |
SE (1) | SE9303740L (en) |
WO (1) | WO1995013078A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH9776A (en) * | 1967-12-11 | 1976-03-17 | M Francis | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use |
NL175882C (en) * | 1977-03-28 | Procter & Gamble | PHARMACEUTICAL PREPARATION CONTAINING AN ANTI-INFLAMMATORY COMPOUND. |
-
1993
- 1993-11-12 SE SE9303740A patent/SE9303740L/en not_active Application Discontinuation
-
1994
- 1994-11-09 AU AU81083/94A patent/AU8108394A/en not_active Abandoned
- 1994-11-09 WO PCT/FI1994/000504 patent/WO1995013078A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU8108394A (en) | 1995-05-29 |
SE9303740D0 (en) | 1993-11-12 |
WO1995013078A1 (en) | 1995-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0891776T3 (en) | Granular composition comprising simethicone and granular anhydrous calcium phosphate | |
EP0520690A3 (en) | Calcium phosphate type hardening material for repairing living hard tissue | |
JPS562962A (en) | Glycolic acid oxidase inhibitor 44substitutedd33hydroxyy33pyrolinee2*55done | |
ZA943744B (en) | Therapeutic substituted guanidines | |
IL108845A0 (en) | Use of anticonvulsants in the treatment of neuro-aids | |
PL308142A1 (en) | Derivatives of 2-amino-4phenyl-4-oxobutyric acids as kynureninase and/or kynurenic 3-hydroxylase inhibitors | |
BG100911A (en) | Biophosphonic acids-sontaining wet-granulated form | |
FI972308A (en) | 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use | |
UA26973A1 (en) | Agent for prophylaxis of the vascular diseases coused by the action of glycoproteinconnected peroxides | |
EP0449405A3 (en) | Use of bisphosphonic acids for the treatment of calcium metabolism disorders | |
MXPA94009086A (en) | Therapeutic substituted guanidines. | |
FI962685A0 (en) | Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis | |
ES2078904T3 (en) | NEW DERIVATIVES OF NEPLANOCINA. | |
SE9303740D0 (en) | Pharmaceutical composition | |
AP9200355A0 (en) | "Therapeutic agent" | |
IL111137A0 (en) | Process for the electrochemical dissolution of sulfur-containing and/or concentrated minerals | |
MX9201825A (en) | PHARMACEUTICAL COMPOSITION CONTAINING CALCITONIN. | |
FI945594A (en) | Thio-substituted cyclic phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism | |
DE19680816D2 (en) | Plant for the production of insoles in shoes | |
FI961171A0 (en) | Method for the treatment of acute myocardial infarction with hirudin and acetylsalicylic acid in patients not receiving thrombolytic therapy | |
IT1268346B1 (en) | METHOD FOR THE MANUFACTURE OF IRON WITH STEEL INSOLE | |
MX9704105A (en) | Kit for osteoporosis treatment cycle. | |
FI945598A0 (en) | Quaternary nitrogen-containing phosphonate compounds for the treatment of abnormal calcium and phosphate metabolism | |
GR77250B (en) | ||
SI0828483T1 (en) | Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9303740-6 Format of ref document f/p: F |